PARIS/LONDON (Reuters) - French drugmaker Sanofi-Aventis is preparing to sell its own generic version of the blockbuster heart medicine Plavix in France, a company spokesman said on Monday. Plavix, ...

LONDON (Reuters) - Sanofi-Aventis and Bristol-Myers Squibb , which are just recovering from defeating generic competition to their top-selling Plavix drug in the United States, now face a similar ...

Clopidogrel is prescribed to help prevent heart attack or stroke. It's a generic medication and is available as the brand-name drug Plavix. It comes as an oral tablet. The cost of clopidogrel can vary ...

News of the expanded indication comes during a showdown between the marketer/manufacturer of the drug, Bristol-Myers Squibb (BMS)/Sanofi-Aventis, and Canadian drug company Apotex, which started ...

New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel. Clopidogrel, currently sold under the brand name Plavix®, ...

The US Food and Drug Administration (FDA) announced it has approved eleven generic versions of Bristol-Myers Squibb and Sanofi's blockbuster blood-thinner Plavix (clopidogrel bisulfate), marking the ...

HOST-EXAM trial, a landmark study recently released at the ACC 2026. The trial sought to determine the effectiveness of ...

PARIS (AP) — The U.S. Justice Department is investigating drug maker Sanofi’s disclosures to the Food and Drug Administration about different responses to its blockbuster blood thinner Plavix. The ...

This year, Peter R. Dolan, the CEO of Bristol-Myers Squibb, was faced with the threat of generic competition for Plavix, an anti-clotting drug with $3.2 billion in annual U.S. sales. In responding to ...

Researchers at the European Society of Cardiology Congress reported that the blood thinner clopidogrel should replace aspirin as a routine pill for preventing heart attacks and strokes for people with ...